MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-HR-03-0002069
Nestor Pharmaceuticals Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹222.19 Cr
▲ 8% YoY
Net profit · FY 2025
₹12.33 Cr
Net margin 5.5%
EBITDA · FY 2025
₹26.54 Cr
EBITDA margin 11.9%
Authorised capital
₹50 Cr
Registered with MCA
Paid-up capital
₹43.18 Cr
Issued & subscribed
Open charges
₹98.66 Cr
Satisfied ₹156.76 Cr
Company age
51 yrs
Est. 1975
Employees · EPFO
567
Provident fund records
About Nestor Pharmaceuticals Limited
Data last updated:
Nestor Pharmaceuticals Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 October 1975 and has been in existence for over 51 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1975PLC007959. Its GSTIN is 06AAACN1547Q1Z6 (Haryana). The company holds 23 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹50 Cr and a paid-up capital of ₹43.18 Cr. It is led by directors including Adarsh Pal Singh and Bhanu Prakash Tiwari.
Its last annual general meeting (AGM) was held on 09 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 106 Dda Shed Phase – II, Okhla Industrial Area, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹222.19 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹12.33 Cr (net margin 5.5%) and EBITDA of ₹26.54 Cr (EBITDA margin 11.9%).
The company has about 567 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Nestoronline and Nestor Pharma. As per MCA filings, the company has open charges of ₹98.66 Cr and satisfied charges of ₹156.76 Cr on record. Court records list 157 cases involving the company, including 91 filed by the company and 66 filed against it; 65 cases are pending. The company has 9 deals on record (3 funding rounds, 3 rights issues, 3 secondary share transfers), with disclosed funding of ₹19.78 Cr; the latest was in March 2024. Its 6 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Hindustan Laboratories Limited with revenue of ₹227.37 Cr. The company has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 35 overdue payments to 23 micro and small suppliers.
Nestor Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-03-0002069). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nestorpharma.com.
Company details
CIN U24231DL1975PLC007959
Registration Number 007959
Incorporation Date 13 October 1975
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 09 June 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HR-03-0002069
Recognitions & Rankings of Nestor Pharmaceuticals
Contact details
Nestor Pharmaceuticals Limited's registered office is in New Delhi, Delhi. Its website is nestorpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 106 Dda Shed Phase – II, Okhla Industrial Area, New Delhi, Delhi, India – 110020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nestor Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Nestor Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Nestor Pharmaceuticals operates two associated brands: nestoronline and Nestor Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Operates an online pharmacy for purchasing prescription and over-the-counter products. | nestoronline.in | |
| A traditional pharmaceutical company producing APIs and formulations. | nestorpharma.com |
Business activity
The main business activity of Nestor Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nestor Pharmaceuticals Limited, buy the company report.
Financials of Nestor Pharmaceuticals Limited
FY 2025 filings availableNestor Pharmaceuticals Limited reported revenue of ₹222.19 Cr (up 8% YoY) for FY 2025.
Revenue · FY 2025
₹222.19 Cr ▲ 8%
Net profit · FY 2025
₹12.33 Cr margin 5.5%
EBITDA · FY 2025
₹26.54 Cr margin 11.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
EBITDA CAGR growth
1 year
▲ 5%
Revenue rose 8% in the latest year. EBITDA rose 5% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹222.19 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.54 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.33 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.9% | ||||
| Net Profit Margin | 5.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nestor Pharmaceuticals Limited, buy the company report.
Board of directors of Nestor Pharmaceuticals Limited
Nestor Pharmaceuticals has 5 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Adarsh Pal Singh | Director | 25 May 2021 | 5 Years 4 Months | Current |
| Bhanu Prakash Tiwari Also directs: Nectarine Ayurveda Private Limited | Director | 18 Mar 2019 | 7 Years 7 Months | Current |
| Rahul Sehgal Also directs: Golden Tulip Farms Private Limited | Director | 25 May 2018 | 8 Years 4 Months | Current |
| Bhisham Singh | Director | 20 Feb 2023 | 3 Years 8 Months | Current |
| Bharat Ram | Director | 25 Jan 2020 | 6 Years 8 Months | Current |
Peer comparison
Nestor Pharmaceuticals Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hindustan Laboratories Limited | ₹227.37 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Salvi Chemical Industries Limited | ₹225.29 Cr (FY 2025) | 47.0% | Mumbai, Maharashtra, India | |||
| Aura Pharmaceuticals Private Limited | ₹223.55 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Venus Biosciences Private Limited | ₹222.32 Cr (FY 2016) | 48.0% | Solan, Himachal Pradesh, India | |||
| Nestor Pharmaceuticals Limitedthis company | ₹222.19 Cr (FY 2025) | ₹12.33 Cr | 5.5% | 8.0% | 567 | New Delhi, Delhi, India |
| Concept Pharmaceuticals Limited | ₹222.11 Cr (FY 2024) | -29.0% | Mumbai, Maharashtra, India | |||
| Naprod Life Sciences Private Limited | ₹219.65 Cr (FY 2025) | 1.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Nestor Pharmaceuticals Limited, buy the company report.
Auditor
Nestor Pharmaceuticals Limited is audited by Deepak Bhargava & Co for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deepak Bhargava & Co | FY 2025 | 021615N |
Shareholding
The shareholding of Nestor Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nestor Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹98.66 Cr
Satisfied charges
₹156.76 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Dec 2021 | 100524789 | Others | ₹2.84 Cr | Open | |
| 09 Dec 2021 | 100512486 | Others | ₹2.15 Cr | Open | |
| 15 Jan 2021 | 100430470 | Others | ₹9.87 Cr | Open | |
| 10 Nov 2010 | 10254197 | Others | ₹36.56 Cr | Open | |
| 08 Jan 2009 | 10140759 | Others | ₹47.24 Cr | Open |
To see the full charge records of Nestor Pharmaceuticals Limited, buy the company report.
Total charge records: 35 View all charges
Deals & funding
Nestor Pharmaceuticals Limited has 9 deals on record (3 funding rounds, 3 rights issues, 3 secondary share transfers), with disclosed funding of ₹19.78 Cr; the latest was in March 2024.
Total deals
9
Funding rounds
3
Rights issues
3
Secondary share transfers
3
Disclosed funding
₹19.78 Cr
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Oct 2020 | Rights issue | ₹14.2 Cr | Investors: 4 individuals |
| Mar 2009 | Funding round | ₹5.3 Cr | Investors: Business Search India Private Limited |
| Sep 2008 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Rudwal Capital Trust Limited, 3 individuals |
| Mar 2008 | Funding round | ₹7.65 Cr | Investors: Rudwal Capital Trust Limited, 3 individuals |
To see the full deal history of Nestor Pharmaceuticals Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Nestor Pharmaceuticals Limited has 157 court cases on record: 91 filed by Nestor Pharmaceuticals, 66 filed against it. 65 cases are pending and 92 are disposed.
Total cases
157
Filed by the company
91
Filed against the company
66
Pending
65
Disposed
92
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 86 | 48 | 43 |
| High courts | 65 | 16 | 21 |
| Supreme Court | 6 | 2 | 1 |
Cases on record (5 of 157)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Rajasthan | Writ petition | Filed by the company against Rajasthan Medical Services Corporation Ltd. and 1 other | Pending |
| High Court, GUJARAT | Special civil application | Filed by the company against Gujarat Medical Services Corporation Ltd. , Govt. of Gujarat and 2 others | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Infinity Laboratories P Ltd | Pending |
| Gauhati High Court | Writ petition | Filed by the company against The Assam Medical Services Corporation Limited, and 1 other | Disposed |
| District court, Central, Delhi | Commercial suit | Filed against the company by Hind Foils LLP | Disposed |
To see the full case history of Nestor Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Nestor Pharmaceuticals Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 35 overdue payments to 23 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 23)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| New Delhi Doaba Carriers,Fbd | |||
| Krish Chemicals Private Limited | |||
| an individual supplier | |||
| Shayona Enterprise Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Nestor Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Nestor Pharmaceuticals Limited has a workforce of 567 employees on its EPFO records as of Nov 20, 2025, across 2 active EPFO establishments.
Employee count
567
Active EPFO establishments
2
Employee growth
-0.7%
GST
Nestor Pharmaceuticals has 23 GST registrations: 4 active and 19 cancelled or inactive.
Total GSTINs
23
Active
4
Cancelled / inactive
19
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACN1547Q1Z6 | Haryana | Active | 01 Jul 2017 |
| 30AAACN1547Q1ZF | Goa | Active | 01 Jul 2017 |
| 09AAACN1547Q2ZZ | Uttar Pradesh | Active | 07 Apr 2022 |
| 27AAACN1547Q3Z0 | Maharashtra | Active | 18 Feb 2025 |
To see the full GST registrations and return filing status of Nestor Pharmaceuticals Limited, buy the company report.
Recent activity
Nestor Pharmaceuticals Limited has 21 board changes on record since 2008: 5 appointments and 16 cessations. The latest: Sonia Sharma ceased to be Company Secretary on 24 Feb 2025.
AGM
Nestor Pharmaceuticals Limited last Annual general meeting of members was held on 09 Jun 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 36.56 Cr registered on 10 Nov 2010 with Charge ID 10254197 was modified on 24 Apr 2025.
Filing
Nestor Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Sonia Sharma ceased to be Company Secretary.
Charges
A charge with Others of Rs. 2.15 Cr registered on 09 Dec 2021 with Charge ID 100512486 was modified on 15 Mar 2023.
Appointed
Bhisham Singh was appointed as Director.
Charges
A charge registered on 04 Oct 2019 via Charge ID 100307142 with Axis Bank Limited was fully satisfied on 13 Feb 2023.
Charges
A charge registered on 04 Oct 2019 via Charge ID 100307159 with Axis Bank Limited was fully satisfied on 13 Feb 2023.
Charges
A charge registered on 04 Oct 2019 via Charge ID 100306982 with Axis Bank Limited was fully satisfied on 13 Feb 2023.
Charges
A charge registered on 18 Sep 2019 via Charge ID 100306860 with Axis Bank Limited was fully satisfied on 13 Feb 2023.
Charges
A charge registered on 18 Sep 2019 via Charge ID 100307034 with Axis Bank Limited was fully satisfied on 13 Feb 2023.
Charges
A charge with Others of Rs. 47.24 Cr registered on 08 Jan 2009 with Charge ID 10140759 was modified on 16 Feb 2022.
89 earlier events are in the company report.
Frequently asked questions
Nestor Pharmaceuticals is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 October 1975 (51+ years old) and is registered under CIN U24231DL1975PLC007959.
Nestor Pharmaceuticals has 5 current directors:
- Adarsh Pal Singh - Director
- Bhanu Prakash Tiwari - Director
- Rahul Sehgal - Director
- Bhisham Singh - Director
- Bharat Ram - Director
The latest financial statements of Nestor Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 09 June 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nestor Pharmaceuticals is 06AAACN1547Q1Z6, registered in Haryana. The company has 23 GST registrations in all, of which 4 are active and 19 are cancelled or inactive. Other active GSTINs include 30AAACN1547Q1ZF (Goa), 09AAACN1547Q2ZZ (Uttar Pradesh), 27AAACN1547Q3Z0 (Maharashtra).
The CIN (Corporate Identification Number) of Nestor Pharmaceuticals is U24231DL1975PLC007959. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nestor Pharmaceuticals has 157 court cases on record: 91 filed by the company and 66 filed against it. 65 are pending. Most are in the district courts.
Nestor Pharmaceuticals was incorporated on 13 October 1975, making it 51+ years old. It is registered with the Registrar of Companies, Delhi.
Nestor Pharmaceuticals has 9 deals on record (3 funding rounds, 3 rights issues, 3 secondary share transfers), with disclosed funding of ₹19.78 Cr; the latest was in March 2024.
The peers of Nestor Pharmaceuticals by revenue are Hindustan Laboratories Limited, Salvi Chemical Industries Limited, Aura Pharmaceuticals Private Limited, Venus Biosciences Private Limited, Concept Pharmaceuticals Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sonia Sharma ceased to be Company Secretary on 24 Feb 2025. Bhisham Singh was appointed as Director on 20 Feb 2023. Adarsh Pal Singh ceased to be Additional Director on 28 Jul 2021. Nestor Pharmaceuticals has 21 board changes on record in total.
Yes, Nestor Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-HR-03-0002069).
Nestor Pharmaceuticals has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 35 overdue payments to 23 micro and small suppliers. The latest return was filed on 29 May 2019.